These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15932563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M.
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.
    Kusamura S, Hutanu I, Baratti D, Deraco M.
    J Surg Oncol; 2013 Jul; 108(1):1-8. PubMed ID: 23720095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
    Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH.
    J Surg Oncol; 2004 Sep 15; 87(4):162-6. PubMed ID: 15334630
    [Abstract] [Full Text] [Related]

  • 12. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M.
    Ann Surg; 2009 Feb 15; 249(2):243-9. PubMed ID: 19212177
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR, Lee WJ, Huang MT, Lin HH.
    Hepatogastroenterology; 2002 Feb 15; 49(46):1157-60. PubMed ID: 12143226
    [Abstract] [Full Text] [Related]

  • 15. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
    Smeenk RM, Verwaal VJ, Zoetmulder FA.
    Eur J Surg Oncol; 2006 Mar 15; 32(2):186-90. PubMed ID: 16303281
    [Abstract] [Full Text] [Related]

  • 16. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T.
    Eur J Surg Oncol; 2007 Mar 15; 33(2):183-7. PubMed ID: 17174516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
    Sugarbaker PH.
    Br J Surg; 2002 Feb 15; 89(2):208-12. PubMed ID: 11856136
    [Abstract] [Full Text] [Related]

  • 19. Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC.
    Ross A, Sardi A, Nieroda C, Merriman B, Gushchin V.
    Eur J Surg Oncol; 2010 Aug 15; 36(8):772-6. PubMed ID: 20561764
    [Abstract] [Full Text] [Related]

  • 20. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF, Wong WM, Yuen MF, Wong BC.
    Cancer; 2005 Aug 15; 104(4):740-6. PubMed ID: 15991243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.